Erratum: Lee AS, Lee JE, Jung YJ, et al. Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. (Kidney International (2013) 83 (50–62) (S0085253815556913)(10.1038/ki.2012.312));Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction

Kidney International

Volumn 83, Issue 1, 2013, Pages 50-62

  Lee, Ae S ^a   Lee, Jung E ^a   Jung, Yu J ^a   Kim, Duk H ^a   Kang, Kyung P ^a   Lee, Sik ^a   Park, Sung K ^a   Lee, Sang Y ^a   Kang, Myung J ^a   Moon, Woo S ^a   Kim, Hyung J ^a   Jeong, Young B ^a   Sung, Mi J ^b   Kim, Won ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

fibrosis; lymphangiogenesis; macrophages; renal tubule; unilateral ureteral obstruction

Indexed keywords

CLODRONIC ACID; MESSENGER RNA; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN C; VASCULOTROPIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; DEPLETION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; LYMPHANGIOGENESIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; URETER OBSTRUCTION;

EID: 84871776288     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2017.07.006     Document Type: Erratum

References (43)

1. Aukland K, Bogusky RT, Renkin EM. Renal cortical interstitium and fluid absorption by peritubular capillaries. Am J Physiol 1994; 266: F175-F184.
2. Baluk P, Tammela T, Ator E et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005; 115: 247-257.
3. Kataru RP, Jung K, Jang C et al. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009; 113: 5650-5659.
4. Kang S, Lee SP, Kim KE et al. Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages. Blood 2009; 113: 2605-2613.
5. Kim KE, Koh YJ, Jeon BH et al. Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Am J Pathol 2009; 175: 1733-1745.
6. Maruyama K, Ii M, Cursiefen C et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005; 115: 2363-2372.
7. Cursiefen C, Chen L, Borges LP et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004; 113: 1040-1050.
8. El-Chemaly S, Malide D, Zudaire E et al. Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc Natl Acad Sci USA 2009; 106: 3958-3963.
9. Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603-612.
10. Matsui K, Nagy-Bojarsky K, Laakkonen P et al. Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 2003; 14: 1981-1989.
11. Saaristo A, Veikkola T, Enholm B et al. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J 2002; 16: 1041-1049.
12. Achen MG, Jeltsch M, Kukk E et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998; 95: 548-553.
13. Morisada T, Oike Y, Yamada Y et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 2005; 105: 4649-4656.
14. Gale NW, Thurston G, Hackett SF et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell 2002; 3: 411-423.
15. Maisonpierre PC, Suri C, Jones PF et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
16. Zhang F, Tang Z, Hou X et al. VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proc Natl Acad Sci USA 2009; 106: 6152-6157.
17. Wu WK, Llewellyn OP, Bates DO et al. IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia. Immunobiology 2010; 215: 796-803.
18. Mantovani A, Romero P, Palucka AK et al. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 2008; 371: 771-783.
19. Kurahara H, Shinchi H, Mataki Y et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 2011; 167: e211-e219.
20. Guo G, Morrissey J, McCracken R et al. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 1999; 277: F766-F772.
21. Kim W, Moon SO, Lee SY et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol 2006; 17: 2474-2483.
22. Morimoto Y, Gai Z, Tanishima H et al. TNF-alpha deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction. Exp Mol Pathol 2008; 85: 207-213.
23. Hwang JS, Park EY, Kim WY et al. Expression of OAT1 and OAT3 in differentiating proximal tubules of the mouse kidney. Histol Histopathol 2010; 25: 33-44.
24. Sabolic I, Valenti G, Verbavatz JM et al. Localization of the CHIP28 water channel in rat kidney. Am J Physiol 1992; 263: C1225-C1233.
25. Clavin NW, Avraham T, Fernandez J et al. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 2008; 295: H2113-H2127.
26. Oka M, Iwata C, Suzuki HI et al. Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 2008; 111: 4571-4579.
27. Avraham T, Daluvoy S, Zampell J et al. Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. Am J Pathol 2010; 177: 3202-3214.
28. Joukov V, Pajusola K, Kaipainen A et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-298.
29. Makinen T, Jussila L, Veikkola T et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 2001; 7: 199-205.
30. Jeon BH, Jang C, Han J et al. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. Cancer Res 2008; 68: 1100-1109.
31. Naruse T, Yuzawa Y, Akahori T et al. P-selectin-dependent macrophage migration into the tubulointerstitium in unilateral ureteral obstruction. Kidney Int 2002; 62: 94-105.
32. Sakamoto I, Ito Y, Mizuno M et al. Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int 2009; 75: 828-838.
33. Redente EF, Higgins DM, Dwyer-Nield LD et al. Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol 2010; 88: 159-168.
34. Kawanishi N, Yano H, Yokogawa Y et al. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc Immunol Rev 2010; 16: 105-118.
35. Zampell JC, Avraham T, Yoder N et al. Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines. Am J Physiol Cell Physiol 2012; 302: C392-C404.
36. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
37. Zhang T, Guan G, Liu G et al. Disturbance of lymph circulation develops renal fibrosis in rats with or without contralateral nephrectomy. Nephrology (Carlton) 2008; 13: 128-138.
38. Avraham T, Clavin NW, Daluvoy SV et al. Fibrosis is a key inhibitor of lymphatic regeneration. Plast Reconstr Surg 2009; 124: 438-450.
39. Curat CA, Vogel WF. Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. J Am Soc Nephrol 2002; 13: 2648-2656.
40. Jung YJ, Kim DH, Lee AS et al. Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury. Am J Physiol Renal Physiol 2009; 297: F952-F960.
41. Lange-Asschenfeldt B, Weninger W, Velasco P et al. Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2- deficient mice. Blood 2002; 99: 538-545.
42. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994; 174: 83-93.
43. Lee AS, Kim DH, Lee JE et al. Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis. Cancer Res 2011; 71: 4506-4517.